Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03779503 · ClinicalTrials.gov registry record · NA
Comparison of Two Daily Disposable Soft Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT03779503 is a NA study that has completed, run by CooperVision. The registered enrollment target is 55 participants.
The verdict
NCT03779503, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The aim of this study was to investigate the short-term clinical performance and subjective acceptance of the two study lenses.
Interventions
- DEVICE midafilcon A
- DEVICE somofilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2019-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03779503
The ClinicalTrials.gov registry entry for NCT03779503 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which midafilcon A is the first listed.
NCT03779503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03779503 about?
NCT03779503 is a clinical study titled "Comparison of Two Daily Disposable Soft Contact Lenses". The aim of this study was to investigate the short-term clinical performance and subjective acceptance of the two study lenses.
What is the current status of trial NCT03779503?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2019-02-08. Estimated completion is 2019-09-18.
What interventions are being tested in trial NCT03779503?
The interventions under investigation include: midafilcon A (DEVICE), somofilcon A (DEVICE).
Who is sponsoring clinical trial NCT03779503?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.